Introduction
The clinical problems requiring a definition of iron status are of three types. They may be associated with iron deficiency, iron overload or a maldistribution of iron within the body.! Biochemical investigations should be directed to determining the status of the main ironcontaining compartments, possibly as a prelude to measuring the pathophysiology of iron loss and flow rates within the body.
The total iron content of the adult body is of the order of 4 g. Daily losses in the male are about 1 mg, and in the menstruating female the mean daily loss may be twice that amount. These losses are normally compensated by iron absorption, and total body iron remains constant in the absence of pathological intake, such as repeated blood transfusion, or losses, usually due to haemorrhage or excessive menstruation. Within the body iron is found at three important sites. Most is used for haemoglobin synthesis which normally accounts for over 60% of the body iron. About 35 mg daily is incorporated into developing erythroblasts for this purpose. No assessment or iron status can be made without reference to the haemoglobin concentration and, when relevant, the total red cell mass.
The second major iron pool may be collectively described as iron 'stores'. This consists largely of ferritin and haernosiderin iron in reticuloendothelial cells and parenchymal cells such as those in the liver. This iron not only forms a deposit against which future demands may be drawn but is also the means by which the metal may be sequestered in a non-toxic form. It remains in dynamic equilibrium with the other iron-requiring tissues. The transport This paper was prepared at the invitation of the Clinical Laboratory Investigations Working Party of the Scientific Committee of the Association of Clinical Biochemists, but does not necessarily reflect their views. 'Correspondence: Professor A Jacobs 168 medium between these large iron pools is plasma transferrin. Iron bound to transferrin accounts for about 0·1 % of the total amount in the body but its rapid turnover ensures that an individual atom has only a transient existence in the plasma pool. Biochemical measurements can be made relating to each of these three iron pools, and some clinical conclusions can be drawn regarding their value.
Haemoglobin
Erythropoiesis presents the main demand for plasma iron. Red cell output will normally be maintained until the supply of iron from recycled haemoglobin and from other iron stores is exhausted. A fall in haemoglobin concentration is thus a late stage in the development of iron deficiency and is a sign that storage iron is exhausted and cannot make up any deficiency resulting from blood loss. In populations where blood loss and iron deficiency are a common problem, measuring the haemoglobin concentration may still be the easiest and most effective way of gauging iron status. However, when erythropoiesis is suppressed as a result of chronic disease such as rheumatoid arthritis, infection or malignancy, iron supply remains adequate but poorly utilised, and, indeed, there will be a net transfer of iron from the red cell to the storage pool.
Serum iron
The principle and practice of measuring the amount or iron bound to circulating transferrin in plasma is well established.? Iron is normally bound to transferrin at neutral pH and can be released by acidification. Once free of its ligand, iron can be maintained in solution only by other suitable ligands or at acid"pH. Quick and simple methods which do not take account of these basic principles and use alkaline detergents to release iron from transferrin are fundamentally unsound. Inadequate methods may well account for the poor interlaboratory agreement of serum iron estimation.
Transferrin iron represents only 0·1% of the total body iron. The whole pool will turn over 10 to 20 times each day even in normal subjects so that anyone iron atom is unlikely to remain in the plasma for longer than 2 h. Indeed, the amount of iron remaining bound to transferrin is simply a transient balance between inflow and outflow and does not reflect the amount of iron that is flowing through the plasma. Even when plasma iron concentration is reduced the total amount of iron flowing through the plasma may be quite normal and depends largely on the demands of erythropoiesis. Rapid changes in the plasma iron level can be brought about by minute differences in supply and demand. A change of only 5% in this balance would halve the serum iron concentration within one day even in normal subjects.
The main limitation in the diagnostic usefulness of the serum iron concentration is its instability; sudden large changes occur even in healthy subjectsr' and differences of more than 20% can often be seen within 10 min. Sometimes the changes are such that serum iron concentration may fall to iron-deficient levels or even rise to levels that might be equated with iron overload. All this will take place without any change in the level of iron stores. Acute infection, inflammation, minor injuries or surgery all precipitate a rapid fall in serum iron concentration. In our experience, simple colds can reduce the serum iron concentration to less than 10 urnol/L even in normal subjects. In many other conditions, typified by rheumatoid arthritis, there are equally low levels of serum iron concentration. The same is true of malignant disease, and in patients with Hodgkin's disease the low serum iron concentration appears to be related to the presence of systemic symptoms rather than the stage of the disease. Thus, low serum iron concentration may result from a number of factors, only one of which is iron deficiency.
Increased serum iron concentration may occur transiently in normal subjects or as the result of disease. Disorders of erythropoiesis, which either increase medullary destruction or result in increased red cell destruction, may all be associated with high serum iron concentrations. Conversely, marrow hypoplasia will also increase the serum iron concentration, and this may be exaggerated by transfusion therapy. Tissue damage, particularly hepatic necrosis caused by viral hepatitis, may be accompanied by marked increases in serum iron concentrations. Iron" overload itself will of course also Diagnostic methods for iron status 169 produce an increase in serum iron levels, and in patients with idiopathic haemochromatosis this may be raised before there is an increase in serum ferritin. It is necessary to distinguish the sustained high serum iron concentration associated with iron overload from that which may be the result of a transient imbalance.
The serum iron concentration, which for so long formed the basis of much clinical investigation of iron metabolism, is now seen to be an entirely inadequate index of storage iron status. There seems little point in continuing to measure serum iron for this purpose, and in our laboratory the assay is no longer used except in the investigation of idiopathic haemochromatosis.
Total iron-binding capacity and transferrin saturation
The total iron-binding capacity is usually measured colorimetrically after saturating the serum transferrin with iron and removing the excess.? Each transferrin molecule has two functionally equivalent binding sites. The proportion of these binding sites that is occupied by iron is determined by the level of plasma iron and the size of the transferrin pool. Because the turnover of plasma proteins such as transferrin is so much longer than that of the iron itself the saturation at anyone instant is largely the result of the plasma iron concentration. Large fluctuations in the serum iron concentration are not matched by changes in the total iron-binding capacity of the transferrin pool. As a result the transferrin saturation in normal subjects and in disease can be just as variable as the serum iron concentration. Although low levels of transferrin saturation are invariably associated with iron deficiency this is not the only condition in which such results may be found. In particular, pregnancy and chronic disease may be associated with equally low levels of transferrin saturation without there being any concurrent iron deficiency. Direct measurements of erythropoietic activity have shown that the marrow receives a normal amount of iron even when the transferrin saturation falls below 16%. Persistently high levels of transferrin saturation are associated with iron overload as a result of the combined effect of a raised serum iron concentration and depressed total ironbinding capacity. In the early stages of idiopathic haemochromatosis it will be raised before excess iron is accumulated in the stores.
As with the serum iron concentration there seems little point in measuring total ironbinding capacity to assess the level of iron stores.
Serum ferritin
Small amounts of ferritin circulate in the plasma, and plasma concentrations are normally closely related to the size of the reticuloendothelial iron stores." The only cause of a low serum ferritin concentration is a reduction in the level of iron stores. This is the key to the use of this estimation in clinical practice. When the stores are depleted serum ferritin falls to something less than 12 to 15 !J.g/L.
In infection and chronic disease where iron is transferred from the red cell compartment to the reticuloendothelial stores, a consequent increase in those stores is reflected in the serum ferritin concentration. In these circumstances serum ferritin concentration can be used to assess whether or not the iron stores are exhausted. If patients are to regain a normal haemoglobin concentration once the disease is cured they will need to have available not just a normal amount of storage iron but an amount equivalent to the deficit in their haemoglobin concentration. Thus in patients with, for example, rheumatoid arthritis and with a haemoglobin concentration of 11 gldL, there should be a level of iron stores sufficient to produce a serum ferritin concentration of more than 70 !J.g/L. The lower the haemoglobin concentration, the higher the serum ferritin concentration should be. A serum ferritin concentration below those levels would not indicate iron deficiency but a level of iron stores that would be inadequate to meet future demands.
Some patients with an absence of stainable iron in the bone marrow may have serum ferritin concentrations of up to 100 IJ/L instead of less than 15 !J.g/L. The reason may not only lie in the unreliability of the assessment of stainable iron in the bone marrow but may also be the direct response of increased ferritin protein synthesis to infection or inflammation (the 'acute phase' response). Mean serum ferritin concentrations are therefore somewhat higher in patients with inflammation than in those with similar levels of stainable iron in the bone marrow but without inflammation. In practice, in patients with anaemia secondary to acute or chronic disease, a serum ferritin concentration of less than 100 ug/L indicates that the level of storage iron is probably inadequate for haemoglobin regeneration.
Iron overload causes high concentrations of serum ferritin but so may liver disease and some forms of cancer. High concentrations can be ascribed to iron overload only after careful consideration of the clinical situation; however, a normal serum ferritin concentration provides good evidence against iron overload. Serum ferritin concentrations are always high in untreated patients with advanced idiopathic haemochromatosis and fall during treatment. The serum ferritin assay should be used together with the measurement of serum iron concentration and total iron-binding capacity in screening for this disorder.
Chelatable irons
Desferrioxamine is able to compete with transferrin for iron in vivo. It seems likely that this iron is derived from an intracellular exchangeable pool located largely within the reticuloendothelial system. The amount of iron available to desferrioxamine from this source is related to the size of that pool and also to the rate at which iron is flowing through it. Thus the amount of iron which desferrioxamine can chelate is increased in patients with increased iron stores but is equally increased in patients with haemolysis. This latter aspect of iron metabolism may be equally as important as the levels of iron stores in determining the level of iron that is chelated by desferrioxamine. Only two-thirds of the total that is chelated may be recovered in the urine, and the measurement of this' would seem to give an indirect and unreliable indication of the level of iron stores.
Stainable irons
The iron present in the reticuloendothelial iron stores can be stained by the Perls reaction and is readily seen in the RE cells of aspirated marrow fragments. This method, however, gives rise to considerable variation in iron staining, and interpretation is subjective. Variation between and within observers is a well recognised limitation of all histological assessments, and this applies to marrow iron grading. While there may be ready agreement as to the presence of an excessive amount be iron, this agreement becomes more difficult as the amount of stainable iron decreases. The visual assessment of a complete absence of stainable iron is particularly difficult. This is generally the point that the haematologist is trying to resolve. It has been shown that the correspondence between the histological iron grade and the measured iron content of a bone marrow sample is particularly weak at this point, and the absence of visible stainable bone marrow cannot be equated with depleted iron stores. This limitation together with the inconvenience of bone marrow sampling limits the practical usefulness of this investigation.
Free erythrocyte protoporphyrln''
This assay has been carried out for some years as a screening test for lead poisoning. More recently, there has been interest in its use for evaluating iron supply to the bone marrow. This is because the protoporphyrin concentration increases from about 35 llg/l00 mL red blood cells in the healthy population to about 200 llg/l00 mL in severe iron deficiency. In the original method protoporphyrin concentrations were measured fluorimetrically after extraction of the porphyrin from whole blood. A later, widely used method directly measures the fluorescence of zinc protoporphyrin (Ilg/g haemoglobin) in an instrument called a haernatofluorimeter. The small sample size (about 20 ul, of venous or skin puncture blood), simplicity, rapidity and reproducibility within a laboratory are advantages. However, chronic diseases which reduce serum iron concentration but do not reduce iron stores also increase protoporphyrin levels. The measurement of erythrocyte protoporphyrin levels as an indicator of iron deficiency has particular advantages in paediatric haematology and in large-scale surveys where the small sample size and simplicity of the test are important. However, in the general clinical laboratory it provides less information about iron storage levels in anaemic patients than the serum ferritin assay and provides no help in the diagnosis of iron overload.
What to do in practice
In the interpretation of tests of iron status it is always important to know whether the patient is anaemic. Measurement of serum iron concentration is of little value. In our laboratory it is used only for the calculation of ferrokinetic data. Transferrin saturation is a valuable Diagnostic methods for iron status 171 screening test for idiopathic haemochromatosis, either in relatives of patients or in the general population, and is usually raised to above 60% before any increase in serum ferritin is observed. We do not measure transferrin saturation for any other purpose. Serum ferritin estimation is the most useful index of iron status. Low levels are diagnostic of iron deficiency. In patients with depressed erythropoiesis and anaemia (whether from aplasia, pernicious anaemia or inflammatory disease) normal serum ferritin levels do not necessarily imply that there is enough iron in the body to replenish the red cell mass. High concentrations may be due to iron overload but also to liver damage. Normal concentrations do not exclude the diagnosis of idiopathic haemochromatosis in the early stages of iron accumulation. The measurement of urinary iron after administration of desferrioxamine is not a useful test of iron stores. The amount chelated in vivo depends on many factors including ascorbic acid status and erythropoietic activity of the marrow. The proportion of chelate excreted in the faeces is variable. More extensive investigations of iron status depend on the specific clinical problem and should be planned for the individual patient.
